Yervoi 50mg Injection
Marketer
Bristol Myers Squibb
Salt Composition
Ipilimumab (50mg)
Overview Yervoi 50mg Injection
Ipilimumab 50mg injection treats metastatic or surgically unresectable melanoma. This immunotherapy enhances the body's natural defenses to target and destroy cancer cells, hindering their growth and spread. Administration is strictly by a healthcare professional; self-injection is dangerous and may lead to severe adverse reactions. The medication is intravenously administered, with dosage and treatment length determined by your physician. Complete the prescribed course of injections. Pre-treatment and ongoing blood tests are usually required. Common side effects include fatigue, nausea, diarrhea, pruritus, rash, emesis, and cephalgia. Report persistent or bothersome side effects to your doctor, who can offer management strategies. During infusion, immediately report chills, rash, flushing, dyspnea, dizziness, or syncope. Before treatment, disclose any immune deficiencies, organ transplantation history, or liver conditions. Inform your doctor of all medications, including prescription drugs, over-the-counter remedies, vitamins, and herbal products. This medication is contraindicated during pregnancy and breastfeeding due to potential fetal harm. Women planning pregnancy should utilize effective contraception throughout treatment and for three months post-treatment.
Uses of Yervoi 50mg Injection
Managing Melanoma
Major Benefits of Yervoi 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Yervoi 50mg Injection:
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
- Rash
- Flu
- Dermatitis
- Bronchitis (inflammation of the airways)
- Eczema
- Swelling of lymph nodes
- Oropharyngeal pain
How to use Yervoi 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Yervoi 50mg Injection works:
Ipilimumab 50mg injection stimulates the body's defense mechanisms to target cancerous cells, achieved by boosting the proliferation of specific immune cells and enhancing overall immunity.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Yervoi 50mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Yervoi 50mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Imfinzi 50mg Injection may pose risks for breastfeeding infants. Available human data indicate potential transfer to breast milk, posing a possible threat to the nursing child.
DrivingCONSULT YOUR DOCTOR
Yervoi 50mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Ipilimumab 50mg injection poses no safety concerns for use in patients with renal impairment. No alteration of the ipilimumab 50mg injection dosage is advised.
LiverSAFE IF PRESCRIBED
Ipilimumab 50mg injection poses no safety concerns for patients with hepatic impairment; dose modification is unnecessary.
What if you forget to take Yervoi 50mg Injection :
NA
Facts to Know About Yervoi 50mg Injection
| Label | Value |
|---|---|
| Type of Compound | Amino acid chains |
| Potential for Dependence | None. |
| Type of Medication | Cancer therapies |
| Mechanism of Action | Laboratory-produced antibodies |
3,018 People bought this recently